Trial · NCT02686138
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Subjects With Overall Response for 6 Out of 12 Weeks | 50mg BID | 107 | Participants | ||
| Percentage of Subjects With Overall Response for 6 Out of 12 Weeks | Placebo | 71 | Participants | ||
| Percentage of Subjects With Overall Complete Spontaneous Bowel Movement (CSBM) Response for 6 Out of 12 Weeks | 50mg BID | 139 | Participants | ||
| Percentage of Subjects With Overall Complete Spontaneous Bowel Movement (CSBM) Response for 6 Out of 12 Weeks | Placebo | 100 | Participants | ||
| Percentage of Subjects With Overall Abdominal Pain Response for 6 Out of 12 Weeks | 50mg BID | 146 | Participants | ||
| Percentage of Subjects With Overall Abdominal Pain Response for 6 Out of 12 Weeks | Placebo | 115 | Participants | ||
| Percentage of Subjects With Overall Response for 13 Out of 26 Weeks | 50mg BID | 104 | Participants | ||
| Percentage of Subjects With Overall Response for 13 Out of 26 Weeks | Placebo | 73 | Participants | ||
| Percentage of Subjects With Overall Complete Spontaneous Bowel Movement (CSBM) Response for 13 Out of 26 Weeks | 50mg BID | 121 | Participants | ||
| Percentage of Subjects With Overall Complete Spontaneous Bowel Movement (CSBM) Response for 13 Out of 26 Weeks | Placebo | 93 | Participants | ||
| Percentage of Subjects With Overall Abdominal Pain Response for 13 Out of 26 Weeks | 50mg BID | 147 | Participants | ||
| Percentage of Subjects With Overall Abdominal Pain Response for 13 Out of 26 Weeks | Placebo | 120 | Participants | ||
| Percentage of Subjects With Overall Response for 9 Out of 12 Weeks | 50mg BID | 54 | Participants | ||
| Percentage of Subjects With Overall Response for 9 Out of 12 Weeks | Placebo | 16 | Participants | ||
| Percentage of Subjects With Overall Complete Spontaneous Bowel Movement (CSBM) Response for 9 Out of 12 Weeks | 50mg BID | 65 | Participants | ||
| Percentage of Subjects With Overall Complete Spontaneous Bowel Movement (CSBM) Response for 9 Out of 12 Weeks | Placebo | 18 | Participants | ||
| Percentage of Subjects With Overall Abdominal Pain Response for 9 Out of 12 Weeks | 50mg BID | 105 | Participants | ||
| Percentage of Subjects With Overall Abdominal Pain Response for 9 Out of 12 Weeks | Placebo | 80 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02686138/results